Reports Q2 revenue $8.4B, consensus $8.27B. “Our momentum is building as we keep executing on our commitments, delivering yet another consecutive quarter of strong results that came in ahead of expectations,” said Geoff Martha, Medtronic (MDT) chairman and chief executive officer. “Innovation matters, and innovation is really driving our growth today. As we look ahead, we’re confident that this diversified growth will keep going, especially given the strength of our pipeline in high-impact markets that will allow us to benefit even more patients around the world.”
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MDT:
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, November 18 – November 21, 2024
- Medtronic (MDT) Q2 Earnings Cheat Sheet
- Medtronic sued by Hexagon Health over hernia mesh patents
- Medtronic, Ping An Health form strategic partnership at China CIIE
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
